Bumrungrad Hospital PCL (BKK:BH)

Market Cap	142.70B +13.2%
Revenue (ttm)	25.49B -0.1%
Net Income	7.57B +0.6%
EPS	8.72 +0.6%
Shares Out	794.97M
PE Ratio	20.58
Forward PE	18.72
Dividend	5.00 (2.79%)
Ex-Dividend Date	Mar 17, 2026

Volume	4,478,607
Open	180.50
Previous Close	179.50
Day's Range	177.50 - 181.00
52-Week Range	130.00 - 214.00
Beta	0.24
Analysts	Buy
Price Target	201.41 (+13.15%)
Earnings Date	Aug 14, 2026

About Bumrungrad Hospital PCL

Bumrungrad Hospital Public Company Limited owns and operates hospitals and healthcare centers in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, pediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic, dialysis, radiology and nuclear medicine, digestive disease, ear, nose, throat, emergency, endocrinology, esperance, diabetes, expatriate liaison, eye...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1975
• Employees: 3,253
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: BH

Financial Performance

In 2025, Bumrungrad Hospital PCL's revenue was 25.45 billion, a decrease of -1.60% compared to the previous year's 25.86 billion. Earnings were 7.51 billion, a decrease of -3.38%.